drugset / Trial / NCT05023395
Safety and Efficacy of MEE-HU Medicus
Phase 2
Unknown
200 enrolled
Dr. Ahmed Ismail
Helwan University · collabThe Cairo Kidney Center · collabTheodor Bilharz Research Institute · collabZagazig University · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
Primary objective: is evaluation of the investigational product's safety and evaluation of its effect, in combination with antimicrobial treatment, on urine culture (microbiological cure, no microbial growth on 24-48 hrs culture). The secondary objective: is evaluation of the investigational product's effect, in combination with antimicrobial treatment, on disease related symptoms (Clinical cure, disappearance of symptoms and signs).
Timeline
- Start
- 2021-10-23
- Primary completion
- 2024-03-24
- Completion
- 2024-05-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MEE-HU Medicus | Unknown | — | Oral |